Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial-Reference-Cited by-同舟云学术

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial

Published:2022-08-08 Issue:12 Volume:24 Page:2319-2330
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Succurro Elena¹²^ORCID,Vizza Patrizia¹,Papa Annalisa³,Miceli Sofia¹,Cicone Francesco³,Fiorentino Teresa Vanessa¹,Sciacqua Angela¹²,Andreozzi Francesco¹²,Veltri Pierangelo¹,Cascini Giuseppe Lucio³,Sesti Giorgio⁴

Affiliation:

1. Department of Medical and Surgical Sciences University Magna Graecia of Catanzaro Catanzaro Italy

2. Research Center for the Prevention and Treatment of Metabolic Diseases (CR METDIS) University Magna Graecia of Catanzaro Catanzaro Italy

3. Department of Experimental and Clinical Medicine Magna Graecia University of Catanzaro Catanzaro Italy

4. Department of Clinical and Molecular Medicine University of Rome‐Sapienza Rome Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14816

Reference58 articles.

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

2. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

4. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

5. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human cardiac metabolism;Cell Metabolism;2024-07

2. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review;Biomedicine & Pharmacotherapy;2024-06

3. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects;Cardiovascular Diabetology;2024-04-26

4. Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes: A Coronary Artery Analysis;International Journal of Molecular Sciences;2023-02-07

5. Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance;Cardiovascular Diabetology;2023-01-09